- Report
- June 2026
- 135 Pages
Global
From €3613EUR$3,999USD£3,135GBP
- Report
- May 2026
- 139 Pages
Global
From €3613EUR$3,999USD£3,135GBP
- Report
- May 2026
- 143 Pages
Global
From €3613EUR$3,999USD£3,135GBP
- Report
- April 2026
- 137 Pages
Global
From €3613EUR$3,999USD£3,135GBP
- Report
- April 2026
- 135 Pages
Global
From €3613EUR$3,999USD£3,135GBP
- Report
- April 2026
- 143 Pages
Global
From €3613EUR$3,999USD£3,135GBP
- Report
- March 2026
- 292 Pages
Global
From €2258EUR$2,500USD£1,960GBP
- Report
- February 2026
- 306 Pages
Global
From €2258EUR$2,500USD£1,960GBP
- Report
- January 2026
- 185 Pages
Global
From €4065EUR$4,500USD£3,527GBP
- Report
- July 2025
- 350 Pages
Global
From €4471EUR$4,949USD£3,879GBP
- Report
- June 2026
- 142 Pages
Global
From €5285EUR$5,850USD£4,586GBP
- Report
- February 2026
- 160 Pages
Global
From €3749EUR$4,150USD£3,253GBP
- Report
- February 2026
- 160 Pages
Global
From €3749EUR$4,150USD£3,253GBP
- Report
- June 2025
- 147 Pages
Global
From €3568EUR$3,950USD£3,096GBP
- Clinical Trials
- February 2026
- 361 Pages
Global
From €3117EUR$3,450USD£2,704GBP
- Report
- September 2025
- 27 Pages
Global
From €9029EUR$9,995USD£7,835GBP
- Clinical Trials
- August 2025
- 551 Pages
Global
From €3117EUR$3,450USD£2,704GBP
- Report
- August 2025
- 115 Pages
Global
From €16256EUR$17,995USD£14,106GBP
- Report
- March 2026
- 200 Pages
Global
From €4512EUR$4,995USD£3,915GBP
- Report
- February 2026
- 194 Pages
Global
From €4512EUR$4,995USD£3,915GBP

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics.
The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more